Posts tagged "secretagogue"

CJC-1295

A synthetic GHRH analog that tells your pituitary to release its own growth hormone, not inject someone else's.

CJC-1295 is a 29-amino acid GHRH analog engineered to resist enzymatic breakdown. It stimulates endogenous GH pulses rather than flooding the system with synthetic hormone, offering a fundamentally different risk-benefit profile to direct HGH therapy.

cjc-1295growth hormoneghrhipamorelinsecretagogue+1

PeptidesPeptide

Ipamorelin

A selective ghrelin mimetic that triggers your pituitary to release growth hormone without touching cortisol, prolactin, or appetite.

Ipamorelin is a synthetic pentapeptide and the first truly selective growth hormone secretagogue. It binds the GHS-R1a receptor to trigger pulsatile GH release without the hormonal side-channel activation that defined earlier peptides like GHRP-6.

ipamorelingrowth hormone

PeptidesPeptide

MK-677 (Ibutamoren)

The oral compound that reliably raises GH and IGF-1 to youthful levels, delivers measurable gains in lean mass and sleep architecture, yet consistently failed to translate those biomarker wins into functional outcomes across 30 years of clinical trials.

MK-677 (Ibutamoren) is a non-peptide, orally active growth hormone secretagogue that selectively agonises the ghrelin receptor (GHS-R1a). It increases 24-hour GH secretion by up to 97% and IGF-1 by 60-79%, producing verified gains in fat-free mass and sleep quality. However, the lean mass does not translate to strength, the bone turnover does not translate to density, and insulin resistance is a consistent pharmacological cost.

mk-677

secretagogue

secretagogue

Protocols

CJC-1295

Ipamorelin

MK-677 (Ibutamoren)

Protocols

CJC-1295

Ipamorelin

MK-677 (Ibutamoren)